2012 (v1)
Publication
No description
Uploaded on: March 31, 2023
-
-
2018 (v1)Publication
The efficacy of tocilizumab (TCZ), a monoclonal antibody to the interleukin (IL)-6 receptor, in suppressing disease activity in glucocorticoid-naïve patients with new-onset polymyalgia rheumatica (PMR) was studied. Its effect on a panel of cytokines and growth factors was evaluated. Three patients, fulfilling the PMR ACR/EULAR criteria,...
Uploaded on: April 14, 2023 -
2009 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2010 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2013 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2021 (v1)Publication
No description
Uploaded on: February 4, 2024 -
2012 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2014 (v1)Publication
No description
Uploaded on: December 2, 2022 -
2013 (v1)Publication
No description
Uploaded on: May 13, 2023 -
2021 (v1)Publication
Objective Polymyalgia rheumatica (PMR) is an inflammatory disorder, more common in the elderly, characterised by girdle pain and stiffness, constitutional symptoms and raised serological markers of inflammation. Studies on the seasonality of onset of PMR have shown conflicting results, possibly due to the different diagnostic criteria and onset...
Uploaded on: January 31, 2024 -
2012 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2014 (v1)Publication
No description
Uploaded on: April 14, 2023